Bluebird Bio shares are trading higher after B of A Securities maintained a Buy rating on the stock and raised its price target from $11 to $12.
Portfolio Pulse from Benzinga Newsdesk
Bluebird Bio's stock (BLUE) is trading higher following an endorsement from B of A Securities, which maintained a Buy rating and increased the price target from $11 to $12.
December 11, 2023 | 5:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bluebird Bio's stock price is positively impacted by B of A Securities' maintained Buy rating and raised price target from $11 to $12.
Analyst ratings and price target adjustments are significant drivers of stock price movements in the short term. The increase in price target by B of A Securities suggests a positive outlook for Bluebird Bio, which can lead to increased investor confidence and upward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100